Bal Pharma Limited — Others, 03-01-2025: Structural Digital Database

Bal Pharma Limited's Compliance Officer, Abdul Basith, has confirmed the establishment of a Structured Digital Database (SDD) as per insider trading regulations. The company successfully documented all unpublished price-sensitive information (UPSI) from the previous quarter and has maintained an audit trail for compliance purposes. Importantly, there were no noted noncompliance issues during this timeframe.

This update reinforces Bal Pharma's commitment to regulatory adherence and enhances investor confidence regarding governance practices. A well-maintained SDD could signify a positive outlook for operational integrity and mitigate potential risks associated with insider trading.